272 related articles for article (PubMed ID: 33231372)
1. Periplocin inhibits the growth of pancreatic cancer by inducing apoptosis via AMPK-mTOR signaling.
Xie G; Sun L; Li Y; Chen B; Wang C
Cancer Med; 2021 Jan; 10(1):325-336. PubMed ID: 33231372
[TBL] [Abstract][Full Text] [Related]
2. DT-13 inhibits the proliferation of pancreatic cancer by inducing apoptosis via AMPK-mTOR signaling.
Xie G; Tong F; Xu M; Shu Y; Li Z
Biochem Biophys Res Commun; 2024 Feb; 695():149451. PubMed ID: 38176173
[TBL] [Abstract][Full Text] [Related]
3. Periplocin Induces Apoptosis of Pancreatic Cancer Cells through Autophagy via the AMPK/mTOR Pathway.
Zhang H; Wang Y; Zhang Y; Zheng B; Wang X; Chen J; Chen B; Xie G; Yang L
J Oncol; 2022; 2022():8055004. PubMed ID: 35847371
[TBL] [Abstract][Full Text] [Related]
4. MK8722, an AMPK activator, inhibiting carcinoma proliferation, invasion and migration in human pancreatic cancer cells.
Wang C; Huang B; Sun L; Wang X; Zhou B; Tang H; Geng W
Biomed Pharmacother; 2021 Dec; 144():112325. PubMed ID: 34656065
[TBL] [Abstract][Full Text] [Related]
5. Baohuoside-1 targeting mTOR inducing apoptsis to inhibit hepatocellular carcinoma proliferation, invasion and migration.
Guo Y; Zhu H; Weng M; Chen B; Wang C; Sun L
Biomed Pharmacother; 2020 Aug; 128():110366. PubMed ID: 32526459
[TBL] [Abstract][Full Text] [Related]
6. Periplocin Extracted from Cortex Periplocae Induced Apoptosis of Gastric Cancer Cells via the ERK1/2-EGR1 Pathway.
Li L; Zhao LM; Dai SL; Cui WX; Lv HL; Chen L; Shan BE
Cell Physiol Biochem; 2016; 38(5):1939-51. PubMed ID: 27160973
[TBL] [Abstract][Full Text] [Related]
7. DT-13 inhibited the proliferation of colorectal cancer via glycolytic metabolism and AMPK/mTOR signaling pathway.
Wei X; Mao T; Li S; He J; Hou X; Li H; Zhan M; Yang X; Li R; Xiao J; Yuan S; Sun L
Phytomedicine; 2019 Feb; 54():120-131. PubMed ID: 30668361
[TBL] [Abstract][Full Text] [Related]
8. Ad-apoptin inhibits glycolysis, migration and invasion in lung cancer cells targeting AMPK/mTOR signaling pathway.
Song G; Fang J; Shang C; Li Y; Zhu Y; Xiu Z; Sun L; Jin N; Li X
Exp Cell Res; 2021 Dec; 409(2):112926. PubMed ID: 34793774
[TBL] [Abstract][Full Text] [Related]
9. Licoricidin inhibits the growth of SW480 human colorectal adenocarcinoma cells in vitro and in vivo by inducing cycle arrest, apoptosis and autophagy.
Ji S; Tang S; Li K; Li Z; Liang W; Qiao X; Wang Q; Yu S; Ye M
Toxicol Appl Pharmacol; 2017 Jul; 326():25-33. PubMed ID: 28416456
[TBL] [Abstract][Full Text] [Related]
10. Honokiol activates AMP-activated protein kinase in breast cancer cells via an LKB1-dependent pathway and inhibits breast carcinogenesis.
Nagalingam A; Arbiser JL; Bonner MY; Saxena NK; Sharma D
Breast Cancer Res; 2012 Feb; 14(1):R35. PubMed ID: 22353783
[TBL] [Abstract][Full Text] [Related]
11. Chloroxine inhibits pancreatic cancer progression through targeted antagonization of the PI3K/AKT/mTOR signaling pathway.
Lin M; Xiao Y; Dai Y; Mao Y; Xu L; Zhang Q; Chen Z
Clin Transl Oncol; 2024 Apr; 26(4):951-965. PubMed ID: 37848695
[TBL] [Abstract][Full Text] [Related]
12. Isogambogenic Acid Inhibits the Growth of Glioma Through Activation of the AMPK-mTOR Pathway.
Zhao W; Peng F; Shu M; Liu H; Hou X; Wang X; Ye J; Zhao B; Wang K; Zhong C; Xue L; Gao M; Liu Y; Zhao S
Cell Physiol Biochem; 2017; 44(4):1381-1395. PubMed ID: 29186708
[TBL] [Abstract][Full Text] [Related]
13. Catechol enhances chemo‑ and radio‑sensitivity by targeting AMPK/Hippo signaling in pancreatic cancer cells.
Moon JY; Ediriweera MK; Ryu JY; Kim HY; Cho SK
Oncol Rep; 2021 Mar; 45(3):1133-1141. PubMed ID: 33650657
[TBL] [Abstract][Full Text] [Related]
14. Tanshinone I attenuates the malignant biological properties of ovarian cancer by inducing apoptosis and autophagy via the inactivation of PI3K/AKT/mTOR pathway.
Zhou J; Jiang YY; Chen H; Wu YC; Zhang L
Cell Prolif; 2020 Feb; 53(2):e12739. PubMed ID: 31820522
[TBL] [Abstract][Full Text] [Related]
15. Desmoplasia suppression by metformin-mediated AMPK activation inhibits pancreatic cancer progression.
Duan W; Chen K; Jiang Z; Chen X; Sun L; Li J; Lei J; Xu Q; Ma J; Li X; Han L; Wang Z; Wu Z; Wang F; Wu E; Ma Q; Ma Z
Cancer Lett; 2017 Jan; 385():225-233. PubMed ID: 27773749
[TBL] [Abstract][Full Text] [Related]
16. Saikosaponin A inhibits the activation of pancreatic stellate cells by suppressing autophagy and the NLRP3 inflammasome via the AMPK/mTOR pathway.
Cui L; Li C; Zhuo Y; Yang L; Cui N; Li Y; Zhang S
Biomed Pharmacother; 2020 Aug; 128():110216. PubMed ID: 32497863
[TBL] [Abstract][Full Text] [Related]
17. A novel DDIT3 activator dehydroevodiamine effectively inhibits tumor growth and tumor cell stemness in pancreatic cancer.
Zhu SL; Qi M; Chen MT; Lin JP; Huang HF; Deng LJ; Zhou XW
Phytomedicine; 2024 Jun; 128():155377. PubMed ID: 38503154
[TBL] [Abstract][Full Text] [Related]
18. Scutellarin inhibits human renal cancer cell proliferation and migration via upregulation of PTEN.
Deng W; Han W; Fan T; Wang X; Cheng Z; Wan B; Chen J
Biomed Pharmacother; 2018 Nov; 107():1505-1513. PubMed ID: 30257368
[TBL] [Abstract][Full Text] [Related]
19. SB365 inhibits angiogenesis and induces apoptosis of hepatocellular carcinoma through modulation of PI3K/Akt/mTOR signaling pathway.
Hong SW; Jung KH; Lee HS; Choi MJ; Son MK; Zheng HM; Hong SS
Cancer Sci; 2012 Nov; 103(11):1929-37. PubMed ID: 22909393
[TBL] [Abstract][Full Text] [Related]
20. Effects of evodiamine on PI3K/Akt and MAPK/ERK signaling pathways in pancreatic cancer cells.
Hong Z; Wang Z; Zhou B; Wang J; Tong H; Liao Y; Zheng P; Jamshed MB; Zhang Q; Chen H
Int J Oncol; 2020 Mar; 56(3):783-793. PubMed ID: 31922213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]